Position in INVA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$10,184,266
+$25,790 QoQ
Shares Held
437,093
-14.0% QoQ
Ownership
0.592%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.0027293962612.ToString("F0")%
Shared 0.ToString("F0")%
None 0.9972706037387924.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Derivatives in INVA
reported options exposure · as of Jun 30, 2020CallValue
$1,479,084
CallShares
105,800
PutValue
$6,990,000
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. INVA ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in INVA
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,184,266 | 437,093 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $10,158,476 | 508,178 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $10,445,715 | 572,368 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,060,048 | 251,869 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,886,451 | 545,309 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,736,736 | 676,469 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,954,159 | 308,346 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,574,025 | 278,904 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,264,590 | 542,296 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,736,848 | 357,659 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $8,136,351 | 626,355 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,462,172 | 193,415 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,817,575 | 428,229 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,145,243 | 463,792 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $261,793 | 22,549 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $9,408,097 | 637,405 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $12,459,348 | 643,894 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,971,793 | 520,104 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,701,277 | 401,034 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,797,740 | 581,487 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,868,716 | 658,470 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $10,426,853 | 841,554 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,819,731 | 174,137 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,990,000 | 500,000 | Put | Defined | 2020-07-31 | |
| 2020-06-30 | $7,322,192 | 523,762 | Shares | Defined | 2020-07-31 | |
| 2020-06-30 | $1,479,084 | 105,800 | Call | Defined | 2020-07-31 | |
| 2020-03-31 | $6,101,557 | 518,840 | Shares | Defined | 2020-05-01 | |
| 2020-03-31 | $6,938,400 | 590,000 | Put | Defined | 2020-05-01 | |
| 2020-03-31 | $5,782,392 | 491,700 | Call | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||